Literature DB >> 24305574

Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus.

Ben Lopman, Kirsten Simmons, Manoj Gambhir, Jan Vinjé, Umesh Parashar.   

Abstract

The pathogenicity of norovirus is definitively established. However, norovirus is frequently detected in the stool of healthy individuals. To gain understanding of the apparent high prevalence of asymptomatic infection, we analyzed a dynamic transmission model of norovirus infection, disease, and immunity. We simulated norovirus epidemiology in low- and high-transmission settings by varying the basic reproduction number (R0). We predicted annual disease incidence values in children aged 0-4 years of 25% with a low R0 and 29% with a high R0. However, the point prevalence of asymptomatic infection rose sharply from 3% to 48% from the low to high R0 settings. Among older children and adults, the models projected that incidence of disease would rise from 6% to 16% from the low to high R0 settings, whereas asymptomatic infection prevalence was lower in this age group. Asymptomatic prevalence of norovirus can change dramatically with small changes in R0. The ratio of prevalence in cases to controls could be high in a developed country and close to or even less than 1 in a high-exposure setting, despite similar disease incidence. These findings highlight an important limitation of case-control studies for pathogens for which there is suboptimal diagnostic specificity.

Entities:  

Keywords:  asymptomatic infection; case-control study; immunity; incidence; modeling; norovirus

Mesh:

Year:  2013        PMID: 24305574     DOI: 10.1093/aje/kwt287

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  36 in total

1.  Persistence of Systemic Murine Norovirus Is Maintained by Inflammatory Recruitment of Susceptible Myeloid Cells.

Authors:  Jacob A Van Winkle; Bridget A Robinson; A Mack Peters; Lena Li; Ruth V Nouboussi; Matthias Mack; Timothy J Nice
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

Review 2.  Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis.

Authors:  Sharia M Ahmed; Aron J Hall; Anne E Robinson; Linda Verhoef; Prasanna Premkumar; Umesh D Parashar; Marion Koopmans; Benjamin A Lopman
Journal:  Lancet Infect Dis       Date:  2014-06-26       Impact factor: 25.071

Review 3.  Quantitative Microbial Risk Assessment and Infectious Disease Transmission Modeling of Waterborne Enteric Pathogens.

Authors:  Andrew F Brouwer; Nina B Masters; Joseph N S Eisenberg
Journal:  Curr Environ Health Rep       Date:  2018-06

4.  Dynamics in a simple evolutionary-epidemiological model for the evolution of an initial asymptomatic infection stage.

Authors:  Chadi M Saad-Roy; Ned S Wingreen; Simon A Levin; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

5.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

6.  The impact of shared sanitation facilities on diarrheal diseases with and without an environmental reservoir: a modeling study.

Authors:  Matthew R Just; Stephen W Carden; Sheng Li; Kelly K Baker; Manoj Gambhir; Isaac Chun-Hai Fung
Journal:  Pathog Glob Health       Date:  2018-06-06       Impact factor: 2.894

7.  Birth Cohort Studies Assessing Norovirus Infection and Immunity in Young Children: A Review.

Authors:  Jennifer L Cannon; Benjamin A Lopman; Daniel C Payne; Jan Vinjé
Journal:  Clin Infect Dis       Date:  2019-07-02       Impact factor: 9.079

8.  Attribution of Pediatric Acute Gastroenteritis Episodes and Emergency Department Visits to Norovirus Genogroups I and II.

Authors:  Gillian A M Tarr; Xiao-Li Pang; Ran Zhuo; Bonita E Lee; Linda Chui; Samina Ali; Otto G Vanderkooi; Christine Michaels-Igbokwe; Phillip I Tarr; Shannon E MacDonald; Gillian Currie; Judy MacDonald; Kelly Kim; Stephen B Freedman
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

9.  Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives.

Authors:  Jacob Kocher; Lijuan Yuan
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

Review 10.  The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection.

Authors:  G Belliot; B A Lopman; K Ambert-Balay; P Pothier
Journal:  Clin Microbiol Infect       Date:  2014-08       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.